non GIST sarcomas
Showing 1 - 25 of >10,000
Communication Training Intervention for Large B-Cell Lymphoma
Recruiting
- Lymphoma, B-Cell
- +5 more
- Hematolo-GIST Training
- Participants Appointment
-
New York, New York
- +2 more
Jul 3, 2023
Sarcoma Trial in Turin (Autologous CIK)
Recruiting
- Sarcoma
- Autologous CIK
-
Turin, ItalyAOU Città della Salute e della Scienza di Torino - Presidio Infa
Aug 11, 2022
Non-rhabdomyosarcoma Soft Tissue Sarcoma, Bone Sarcoma Trial in Boston (Proton Beam Radiation)
Active, not recruiting
- Non-rhabdomyosarcoma Soft Tissue Sarcoma
- Bone Sarcoma
- Proton Beam Radiation
-
Boston, Massachusetts
- +1 more
Sep 30, 2021
Sarcoma, Bone, Sarcoma, Soft Tissue, Osteosarcoma Trial in Memphis (Diffusion Weighted Magnetic Resonance Imaging)
Active, not recruiting
- Sarcoma, Bone
- +5 more
- Diffusion Weighted Magnetic Resonance Imaging
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 4, 2022
Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations
Not yet recruiting
- Gastrointestinal Stromal Tumors
- +2 more
- (no location specified)
Jul 15, 2022
Children and Leukemia, Brain Tumors, and Sarcomas
Recruiting
- Leukemia
- +5 more
- Non-Interventional
-
Halle (Saale), GermanyInstitute of Medical Sociology
Oct 5, 2021
Non-metastatic Soft-tissue Sarcoma, Resectable Trial in France (Doxorubicin, Ifosfamide or dacarbazine, At the discretion of the
Recruiting
- Non-metastatic Soft-tissue Sarcoma
- Resectable
- Doxorubicin
- +2 more
-
Bordeaux, France
- +9 more
Jul 27, 2022
Rhabdomyosarcoma, Non-Rhabdo. Soft Tissue Sarcoma Trial in Toronto (18F-FAZA (F18-Fluoroazomycin Arabinoside), Blood Oxygen
Enrolling by invitation
- Rhabdomyosarcoma
- Non-Rhabdo. Soft Tissue Sarcoma
- 18F-FAZA (F18-Fluoroazomycin Arabinoside)
- +3 more
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Nov 24, 2021
Study in Low Risk Gastrointestinal Stromal Tumor (GISTs)
Completed
- GIST
- Treatment of Low Risk GISTs according clinical practice (includes drugs, surgery or any other received treatments)
-
Bologna, BO, Italy
- +12 more
Sep 16, 2022
Thoracic Sarcomas, Thorasic Cancers, Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura Trial run by the NCI
Terminated
- Thoracic Sarcomas
- +4 more
- H1299 cell lysates
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 27, 2021
Gastrointestinal Stromal Tumors, Resected Gastrointestinal Stromal Tumors, Non-metastatic Trial in France (Imatinib maintenance)
Recruiting
- Gastrointestinal Stromal Tumors
- +4 more
- Imatinib maintenance
-
Marseille, Bouches Du Rhône, France
- +16 more
Jul 28, 2021
Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in
Active, not recruiting
- Metastatic Melanoma
- +22 more
- Ipilimumab
- +3 more
-
Birmingham, Alabama
- +24 more
Jan 19, 2023
Sarcoma Trial in Torino (Autologous CIK Dose level 1, Autologous CIK Dose level 2, Autologous CIK Dose level 3)
Withdrawn
- Sarcoma
- Autologous CIK Dose level 1
- +3 more
-
Torino, ItalyOspedale Infantile Regina Margherita - Unit of Paediatric Oncoem
Dec 18, 2020
Sarcoma Trial in France (Combination of MK3475 with Metronomic CP, Combination of MK3475 with Metronomic CP and G100)
Active, not recruiting
- Sarcoma
- Combination of MK3475 with Metronomic CP
- Combination of MK3475 with Metronomic CP and G100
-
Bordeaux, France
- +7 more
May 4, 2021
Clinical Research of Drug Holiday Based on MRD Detection in GIST
Recruiting
- Gastrointestinal Stromal Tumors
-
Beijing, Beijing, ChinaPeking University People's Hospital
May 11, 2023
Ripretinib in Chinese Advanced GIST: a Real World Study
Active, not recruiting
- Gastrointestinal Stromal Tumors
- Ripretinib Oral Tablet
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Jan 15, 2023
Precision Medicine for Every Child With Cancer
Recruiting
- Childhood Cancer
- +5 more
- Whole Genome Sequencing
- +6 more
-
Adelaide, Australia
- +8 more
Jan 24, 2023
Colorectal Cancer Not MSI-H or MMR-deficient, GIST, Oesophageal or Gastric Carcinoma Trial in France (Phase 1 : Regorafenib,
Recruiting
- Colorectal Cancer Not MSI-H or MMR-deficient
- +9 more
- Phase 1 : Regorafenib
- +4 more
-
Bordeaux, France
- +6 more
Dec 6, 2021
Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma Trial in Worldwide (Aldoxorubicin, Investigator's Choice
Completed
- Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma
- Aldoxorubicin
- Investigator's Choice Treatment (Darcabazine, Pazopanib, Gemcitabine + Docetaxel, Doxorubicin, Ifosfamide)
-
Birmingham, Alabama
- +73 more
Mar 28, 2022
Oncogenetic Panel and Integrated Clinical Data Registry Study
Recruiting
- Gastrointestinal Stromal Tumor (GIST)
-
Changhua, Taiwan
- +12 more
Dec 6, 2022
Etiosarc: Environmental Aetiology of Sarcomas FromMulticenter
Recruiting
- Sarcoma
- +3 more
- Environmental, occupational and lifestyle-related exposures
-
Besançon, France
- +9 more
Aug 25, 2021
Metastatic Soft Tissue Sarcoma, Advanced Soft Tissue Sarcoma Trial in Aurora (doxorubicin with AGEN1884 and AGEN2034)
Recruiting
- Metastatic Soft Tissue Sarcoma
- Advanced Soft Tissue Sarcoma
- doxorubicin with AGEN1884 and AGEN2034
-
Aurora, ColoradoUniversity of Colorado Hospital
Jan 4, 2023